Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 132 No. 2930 (2002)

Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders

  • S Oertle
  • H Mauron
  • PN Villiger
DOI
https://doi.org/10.4414/smw.2002.10031
Cite this as:
Swiss Med Wkly. 2002;132:414-414
Published
27.07.2002